Live Breaking News & Updates on Wilson Boucher Capital Management

Stay updated with breaking news from Wilson boucher capital management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Wilson & Boucher Capital Management LLC Reduces Holdings in iShares Broad USD High Yield Corporate Bond ETF (BATS:USHY)

Wilson & Boucher Capital Management LLC reduced its position in shares of iShares Broad USD High Yield Corporate Bond ETF (BATS:USHY – Free Report) by 6.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,800 shares of the […] ....

Exchange Commission , Covestor Ltd , Eversource Wealth Advisors , Winch Advisory Services , Wilson Boucher Capital Management , Boucher Capital Management , Shares Broad , Yield Corporate Bond , Free Report , Advisory Services , Valley Asset Management Partners , Source Wealth Advisors , Yield Constrained ,

Wilson & Boucher Capital Management LLC Purchases 1,000 Shares of VanEck Fallen Angel High Yield Bond ETF (NASDAQ:ANGL)

Wilson & Boucher Capital Management LLC grew its position in VanEck Fallen Angel High Yield Bond ETF (NASDAQ:ANGL – Free Report) by 2.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,100 shares of the company’s stock after acquiring an additional 1,000 […] ....

Envestnet Asset Management Inc , Wright Fund Management , Exchange Commission , Wilson Boucher Capital Management , Wilbanks Smith Thomas Asset Management , Ameriprise Financial Inc , Boucher Capital Management , Vaneck Fallen Angel High Yield Bond , Free Report , Fund Management , Asset Management , Thomas Asset Management , Eck Fallen Angel High Yield Bond , Visit Holdingschannel ,

Wilson & Boucher Capital Management LLC Sells 200 Shares of Abbott Laboratories (NYSE:ABT)

Wilson & Boucher Capital Management LLC trimmed its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,009 shares of the healthcare product maker’s stock after selling 200 shares during the quarter. […] ....

New Zealand General , New Zealand , Raymond James , Roberte Funck , Norges Bank , Charles Schwab Investment Management Inc , Exchange Commission , Fisher Asset Management , Northern Trust Corp , Wilson Boucher Capital Management , Royal Bank , Securities Exchange Commission , Abbott Laboratories , Wellington Management Group , Boucher Capital Management , Free Report , Management Group , Trust Corp , Schwab Investment Management , Asset Management , Laboratories Stock Down , Get Free Report , Gesua Sive Salvadori , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products ,